Osmolex ER (amantadine ER) - Adamas
Osmolex ER: Newly added patents in Orange Book (Orange Book) - Feb 13, 2021 - Expiry on November 23, 2025 and January 22, 2028 
Patent CNS Disorders • Parkinson's Disease
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
 
Feb 13, 2021
 
 
3482ebc7-b700-4722-90ae-3941e59ac3b5.jpg